Search

Christopher Upton

Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )

Most Active Art Unit
1778
Art Unit(s)
1797, 1306, 1308, 1776, 1778, 1724
Total Applications
3146
Issued Applications
2580
Pending Applications
123
Abandoned Applications
451

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14930447 [patent_doc_number] => 20190300861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => METABOLICALLY COMPETENT CELLS, METHODS OF MAKING, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/315675 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10516 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315675
Metabolically competent cells, methods of making, and uses thereof Jul 6, 2017 Issued
Array ( [id] => 14342909 [patent_doc_number] => 20190153427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => DETERMINATION OF RNA IN BLOOD OR OTHER FLUIDS [patent_app_type] => utility [patent_app_number] => 16/315194 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315194 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315194
DETERMINATION OF RNA IN BLOOD OR OTHER FLUIDS Jul 6, 2017 Abandoned
Array ( [id] => 16016083 [patent_doc_number] => 20200182884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES [patent_app_type] => utility [patent_app_number] => 16/312959 [patent_app_country] => US [patent_app_date] => 2017-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -139 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312959 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/312959
METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES Jun 26, 2017 Abandoned
Array ( [id] => 12794956 [patent_doc_number] => 20180156821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS [patent_app_type] => utility [patent_app_number] => 15/632926 [patent_app_country] => US [patent_app_date] => 2017-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632926 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/632926
TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS Jun 25, 2017 Abandoned
Array ( [id] => 11994300 [patent_doc_number] => 20170298455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'COMPOSITION AND METHOD FOR IMAGING STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/631124 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9785 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631124 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/631124
Composition and method for imaging stem cells Jun 22, 2017 Issued
Array ( [id] => 14655621 [patent_doc_number] => 20190234939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Juvenile Atopic Dermatitis Models [patent_app_type] => utility [patent_app_number] => 16/311378 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311378
Juvenile atopic dermatitis models Jun 22, 2017 Issued
Array ( [id] => 14535265 [patent_doc_number] => 20190203254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/322545 [patent_app_country] => US [patent_app_date] => 2017-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11037 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322545
CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF Jun 13, 2017 Abandoned
Array ( [id] => 14310409 [patent_doc_number] => 20190144908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => HIGH CELL DENSITY ANAEROBIC FERMENTATION FOR PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 16/308267 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308267 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308267
HIGH CELL DENSITY ANAEROBIC FERMENTATION FOR PROTEIN EXPRESSION Jun 8, 2017 Abandoned
Array ( [id] => 14930449 [patent_doc_number] => 20190300862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => Herpesvirus with Modified Glycoprotein H for Propagation in a Cell [patent_app_type] => utility [patent_app_number] => 16/307708 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307708 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/307708
Herpesvirus with Modified Glycoprotein H for Propagation in a Cell Jun 7, 2017 Pending
Array ( [id] => 11979615 [patent_doc_number] => 20170283769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'Modified Cells Evoking Reduced Immunogenic Responses' [patent_app_type] => utility [patent_app_number] => 15/616787 [patent_app_country] => US [patent_app_date] => 2017-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616787 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/616787
Modified Cells Evoking Reduced Immunogenic Responses Jun 6, 2017 Abandoned
Array ( [id] => 12580776 [patent_doc_number] => 20180085421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent [patent_app_type] => utility [patent_app_number] => 15/609605 [patent_app_country] => US [patent_app_date] => 2017-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609605 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/609605
Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent May 30, 2017 Abandoned
Array ( [id] => 14567421 [patent_doc_number] => 20190211317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES [patent_app_type] => utility [patent_app_number] => 16/305003 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305003 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/305003
PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES May 25, 2017 Abandoned
Array ( [id] => 16446034 [patent_doc_number] => 10837957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => In vitro model for pathological or physiologic conditions [patent_app_type] => utility [patent_app_number] => 15/599821 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 74 [patent_no_of_words] => 31763 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599821 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/599821
In vitro model for pathological or physiologic conditions May 18, 2017 Issued
Array ( [id] => 11949783 [patent_doc_number] => 20170253934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'METHOD FOR SCREENING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/600068 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11357 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600068 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/600068
Method for screening induced pluripotent stem cells May 18, 2017 Issued
Array ( [id] => 15130175 [patent_doc_number] => 10478524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Tissue-engineered silk organs [patent_app_type] => utility [patent_app_number] => 15/600351 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 27 [patent_no_of_words] => 8393 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600351 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/600351
Tissue-engineered silk organs May 18, 2017 Issued
Array ( [id] => 17513900 [patent_doc_number] => 11293033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => Compositions and methods for genomic integration of nucleic acids into exogenous landing pads [patent_app_type] => utility [patent_app_number] => 16/302079 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 35 [patent_no_of_words] => 37509 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302079 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302079
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads May 17, 2017 Issued
Array ( [id] => 17800210 [patent_doc_number] => 11414491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Targeting PD-L1 on tumor cells [patent_app_type] => utility [patent_app_number] => 16/302403 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 18130 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302403 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302403
Targeting PD-L1 on tumor cells May 17, 2017 Issued
Array ( [id] => 14306539 [patent_doc_number] => 20190142973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A [patent_app_type] => utility [patent_app_number] => 16/098660 [patent_app_country] => US [patent_app_date] => 2017-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098660 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098660
Engineered nucleases useful for treatment of hemophilia A May 2, 2017 Issued
Array ( [id] => 14581813 [patent_doc_number] => 20190218515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => EX VIVO BITE-ACTIVATED T CELLS [patent_app_type] => utility [patent_app_number] => 16/093867 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093867 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/093867
EX VIVO BITE-ACTIVATED T CELLS Apr 11, 2017 Pending
Array ( [id] => 11758522 [patent_doc_number] => 20170205391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS' [patent_app_type] => utility [patent_app_number] => 15/478041 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 19968 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478041 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/478041
DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS Apr 2, 2017 Abandoned
Menu